Amza Ali, MD, is an internationally recognized neurologist with a career-long commitment to advocacy on behalf of people with epilepsy as well as research at the intersection of neurology and underserved populations with a focus on new therapies.

Justin Grant, PhD, has expertise in drug development at Canada’s top research institutes and early-stage biotech companies.

Mary-Elizabeth Gifford is chair of the Global Wellness Institute’s Psychedelics & Healing Initiative and executive vice president of Psyence Group, a biotechnology company developing nature-derived pharmaceutical psilocybin.